During the past decade, Tuğba Atan conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tuğba Atan" are "Fibromyalgia" (2 trials), "Adhesive Capsulitis of Shoulder" (1 trials), "Lipedema" (1 trials), "Parkinson Disease" (1 trials) and "Tinnitus, Subjective" (1 trials). Many other conditions were trialed in "Tuğba Atan" in a lesser frequency.

Most popular intervention types in "Tuğba Atan" are "Behavioral" (2 trials), "Device" (2 trials), "Other" (2 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "0% unweighed BWSTT" (1 trials), "10% unweighed BWSTT" (1 trials), "20% unweighed BWSTT" (1 trials), "Combined decongestive treatment (CDT) & Combined exercise" (1 trials) and "Combined exercise" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tuğba Atan" are 3 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Tuğba Atan". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Tuğba Atan, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tuğba Atan, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".